共 345 条
[1]
Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 765-781
[2]
Parkin DM(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
[3]
Steliarova-Foucher E(2008)Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions Oncologist 13 5-13
[4]
Jemal A(2009)Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Lancet 373 1525-1531
[5]
Siegel R(2010)Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study Lancet Oncol 11 733-740
[6]
Xu J(2000)Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group J Clin Oncol 18 2354-2362
[7]
Ward E(2000)Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy J Clin Oncol 18 2095-2103
[8]
Ramalingam S(2004)Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J Clin Oncol 22 1589-1597
[9]
Belani C(2005)Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 123-132
[10]
Pirker R(2010)Platinum-based second-line treatment in non-small-cell lung cancer: an old new kid on the block? J Clin Oncol 28 24-25